Current Value
$16.951 Year Return
Current Value
$16.951 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XGN | 34.14% | $153.02M | +261.76% | 0.00% |
TBRG | 33.25% | $344.94M | +116.20% | 0.00% |
CARG | 30.36% | $3.43B | +36.05% | 0.00% |
PLTR | 30.31% | $336.29B | +415.56% | 0.00% |
APPS | 28.31% | $577.70M | +170.00% | 0.00% |
ADMA | 28.12% | $4.41B | +50.04% | 0.00% |
MKL | 27.94% | $25.30B | +26.66% | 0.00% |
RNA | 25.92% | $3.79B | -28.98% | 0.00% |
FLXS | 25.91% | $209.14M | +17.62% | 1.79% |
HONE | 25.87% | $525.52M | +5.35% | 3.47% |
AUDC | 25.38% | $286.71M | -11.94% | 3.75% |
IOVA | 25.25% | $644.49M | -77.13% | 0.00% |
AKAM | 24.96% | $11.61B | -15.58% | 0.00% |
TBCH | 24.95% | $281.24M | -6.56% | 0.00% |
G | 24.50% | $7.92B | +42.14% | 1.44% |
SLVM | 24.30% | $2.16B | -21.43% | 3.44% |
DOCN | 24.10% | $2.69B | -11.23% | 0.00% |
DOCS | 23.93% | $11.28B | +121.78% | 0.00% |
IAG | 23.93% | $4.00B | +64.30% | 0.00% |
VNET | 23.90% | $1.84B | +201.73% | 0.00% |
Yahoo
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, Huge Biopharma Australia Pty Ltd., the submission of its patented candidate breakthrough drug, Lucid-21-302 (Lucid-MS), to the Innovative Licensing and Access Pathway (ILAP) Passport program in the United King
SeekingAlpha
Medicus Pharma: High-Risk, But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment
Yahoo
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of
Yahoo
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of
Yahoo
Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raiseTORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™—the scientifically-proven and game-changing beverage that accele
Yahoo
Los Angeles, California--(Newsfile Corp. - June 18, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Quantum BioPharma Ltd.'s (NASDAQ: QNTM) continued progress across its innovative pipeline of treatments for brain disorders and alcohol health.A link to the report is available here: https://files.constantcontact.com/1683279a601/2551ab59-a629-4103-8f4b-fa3fbf21f4a5.pdf?rdr=trueClinical Development MilestonesQuantum BioPha
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PCRX | -34.61% | $1.10B | +8.62% | 0.00% |
AVD | -27.69% | $137.96M | -53.51% | 0.00% |
MITK | -21.54% | $450.63M | -13.17% | 0.00% |
CLX | -18.28% | $15.76B | -5.19% | 3.83% |
PINC | -18.00% | $1.77B | +13.85% | 3.92% |
EL | -14.24% | $33.13B | -9.36% | 1.87% |
SPTN | -12.54% | $898.70M | +41.30% | 3.29% |
FIVN | -12.11% | $2.12B | -33.22% | 0.00% |
MRK | -11.83% | $210.98B | -34.85% | 3.82% |
PUBM | -11.81% | $663.46M | -32.43% | 0.00% |
WBTN | -11.76% | $1.28B | -50.77% | 0.00% |
SAVA | -11.05% | $104.35M | -80.35% | 0.00% |
MOH | -10.92% | $12.39B | -21.20% | 0.00% |
PYPL | -10.86% | $73.62B | +26.19% | 0.00% |
NFE | -10.68% | $965.18M | -82.90% | 0.00% |
ATKR | -10.29% | $2.56B | -46.45% | 1.71% |
NATR | -9.49% | $288.95M | +4.06% | 0.00% |
CNXN | -9.42% | $1.71B | +5.00% | 0.75% |
KVUE | -9.40% | $40.16B | +16.74% | 3.94% |
AQN | -9.19% | $4.63B | -6.40% | 4.49% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FRDM | 22.63% | $1.22B | 0.49% |
EMXC | 22.19% | $13.70B | 0.25% |
GWX | 22.16% | $706.81M | 0.4% |
EWD | 21.91% | $376.15M | 0.54% |
PXF | 21.88% | $2.04B | 0.43% |
CGBL | 21.82% | $2.57B | 0.33% |
ESGE | 21.77% | $5.05B | 0.26% |
XCEM | 21.67% | $1.17B | 0.16% |
AVEM | 21.64% | $10.90B | 0.33% |
CWI | 21.64% | $1.88B | 0.3% |
SPEU | 21.63% | $693.33M | 0.07% |
EEM | 21.55% | $18.41B | 0.72% |
ILF | 21.54% | $1.76B | 0.48% |
IEMG | 21.52% | $97.57B | 0.09% |
ICOW | 21.50% | $1.16B | 0.65% |
PRNT | 21.47% | $77.79M | 0.66% |
ACWX | 21.46% | $6.44B | 0.32% |
EWY | 21.40% | $4.97B | 0.59% |
FXC | 21.38% | $92.85M | 0.4% |
IXUS | 21.37% | $46.09B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VNLA | -<0.01% | $2.62B | 0.23% |
DFIP | -0.05% | $928.51M | 0.11% |
IBTO | -0.06% | $353.51M | 0.07% |
CGCB | -0.12% | $2.51B | 0.27% |
FLGV | 0.12% | $1.02B | 0.09% |
UBND | -0.12% | $1.02B | 0.4% |
IBTP | 0.14% | $142.98M | 0.07% |
UNG | 0.15% | $375.27M | 1.06% |
OWNS | 0.18% | $128.37M | 0.3% |
JSI | -0.21% | $878.22M | 0.49% |
IBMS | 0.25% | $89.61M | 0.18% |
TOTL | 0.25% | $3.80B | 0.55% |
KCCA | 0.27% | $108.37M | 0.87% |
SHM | 0.29% | $3.41B | 0.2% |
YEAR | -0.30% | $1.46B | 0.25% |
GSY | -0.37% | $2.73B | 0.22% |
ULST | -0.38% | $592.38M | 0.2% |
UTEN | -0.42% | $210.57M | 0.15% |
JPST | -0.44% | $31.93B | 0.18% |
MMIN | 0.46% | $322.53M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -21.25% | $184.73M | 0.85% |
TAIL | -16.80% | $94.86M | 0.59% |
USDU | -11.20% | $129.80M | 0.5% |
BTAL | -11.17% | $315.93M | 1.43% |
IVOL | -10.13% | $342.69M | 1.02% |
BILS | -9.47% | $3.80B | 0.1356% |
XHLF | -8.92% | $1.73B | 0.03% |
CARY | -8.71% | $347.36M | 0.8% |
SPTS | -8.67% | $5.77B | 0.03% |
UUP | -8.22% | $196.45M | 0.77% |
XONE | -7.91% | $628.85M | 0.03% |
IBTG | -7.62% | $1.92B | 0.07% |
FTSM | -7.41% | $6.34B | 0.45% |
KMLM | -7.41% | $187.82M | 0.9% |
FMF | -7.32% | $163.23M | 0.95% |
VGSH | -7.03% | $22.68B | 0.03% |
PSQA | -6.97% | $36.49M | 0.2% |
SCHO | -6.88% | $10.98B | 0.03% |
LDUR | -6.87% | $922.12M | 0.5% |
UTWO | -6.49% | $376.33M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
COLM | -<0.01% | $3.48B | -19.70% | 1.90% |
TR | -0.01% | $2.53B | +20.60% | 1.04% |
PTCT | -0.01% | $3.92B | +49.16% | 0.00% |
QS | 0.03% | $5.08B | +28.75% | 0.00% |
GH | 0.03% | $6.35B | +71.14% | 0.00% |
ACHC | -0.05% | $2.27B | -63.21% | 0.00% |
DLX | 0.06% | $755.66M | -23.71% | 7.21% |
ATRC | -0.06% | $1.59B | +37.07% | 0.00% |
CYD | -0.06% | $895.94M | +159.28% | 3.79% |
PLOW | -0.06% | $714.15M | +38.85% | 3.87% |
KNX | 0.06% | $7.81B | -2.66% | 1.42% |
NKE | 0.07% | $110.14B | +1.68% | 2.13% |
PACB | 0.10% | $450.13M | 0.00% | 0.00% |
ANGO | -0.11% | $384.95M | +54.65% | 0.00% |
GRAL | 0.13% | $1.56B | +197.80% | 0.00% |
AEP | -0.13% | $56.65B | +16.73% | 3.49% |
SVV | -0.15% | $1.65B | -12.68% | 0.00% |
SJM | -0.16% | $11.17B | -5.83% | 4.17% |
AKRO | 0.17% | $4.15B | +109.34% | 0.00% |
OFLX | -0.17% | $366.93M | -29.62% | 3.81% |